Julie Ducreux
Julie Ducreux
Chargé de Recherche, Université catholique de Louvain
Adresse e-mail validée de uclouvain.be
Titre
Citée par
Citée par
Année
Type I interferon blockade in systemic lupus erythematosus: where do we stand?
BR Lauwerys, J Ducreux, FA Houssiau
Rheumatology 53 (8), 1369-1376, 2014
952014
Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium
J Ducreux, P Durez, C Galant, A Nzeusseu Toukap, B Van den Eynde, ...
Arthritis & rheumatology 66 (1), 15-23, 2014
602014
Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis …
J Ducreux, FA Houssiau, P Vandepapelière, C Jorgensen, E Lazaro, ...
Rheumatology 55 (10), 1901-1905, 2016
522016
Heterogeneity of synovial molecular patterns in patients with arthritis
BR Lauwerys, D Hernández-Lobato, P Gramme, J Ducreux, A Dessy, ...
PloS one 10 (4), e0122104, 2015
242015
Higher expression of TNFα-induced genes in the synovium of patients with early rheumatoid arthritis correlates with disease activity, and predicts absence of response to first …
A De Groof, J Ducreux, F Humby, AN Toukap, V Badot, C Pitzalis, ...
Arthritis research & therapy 18 (1), 19, 2016
232016
Multi-center harmonization of flow cytometers in the context of the European “PRECISESADS” project
C Jamin, L Le Lann, D Alvarez-Errico, N Barbarroja, T Cantaert, ...
Autoimmunity reviews 15 (11), 1038-1045, 2016
182016
Analysis of sialoadhesin expression on mouse alveolar macrophages
J Ducreux, PR Crocker, R Vanbever
Immunology letters 124 (2), 77-80, 2009
142009
PEGylation of anti-sialoadhesin monoclonal antibodies enhances their inhibitory potencies without impairing endocytosis in mouse peritoneal macrophages
J Ducreux, D Tyteca, B Ucakar, T Medts, PR Crocker, PJ Courtoy, ...
Bioconjugate chemistry 20 (2), 295-303, 2009
82009
The inhibitory potencies of monoclonal antibodies to the macrophage adhesion molecule sialoadhesin are greatly increased following PEGylation
J Ducreux, R Vanbever, PR Crocker
Bioconjugate chemistry 19 (10), 2088-2094, 2008
72008
Crucial biopharmaceutical issues facing macromolecular candidates for inhalation: the role of macrophages in pulmonary protein clearance
J Ducreux, R Vanbever
Respir Drug Deliv Eur 2007, 31-41, 2007
62007
Molecular characterization of monocyte subsets reveals specific and distinctive molecular signatures associated with cardiovascular disease in Rheumatoid Arthritis
P Ruiz-Limon, R Ortega-Castro, N Barbarroja, C Perez-Sanchez, C Jamin, ...
Frontiers in immunology 10, 1111, 2019
42019
IFN alpha kinoid induces neutralizing anti-IFN alpha antibodies that decrease the expression of IFN-induced and B cell activation associated transcripts: analysis of extended …
J Ducreux, P Vandepapeliere, F Colaone, C Roucairol, T Croughs, ...
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 33 (3), S35-S35, 2015
32015
Feasibility of a molecular diagnosis of arthritis based on the iIdentification of specific transcriptomic profiles in knee synovial biopsies
I Focant, DH Lobato, J Ducreux, P Durez, A Nzeusseu Toukap, D Elewaut, ...
Arthritis & Rheumatism 63, 751, 2011
32011
O31 Integrative analysis reveals a molecular stratification of systemic autoimmune diseases
G Barturen, S Babaei, F Català-Moll, M Martínez-Bueno, Z Makowska, ...
Lupus Science & Medicine 7 (Suppl 1), 2020
22020
STAT3 phosphorylation mediates the stimulatory effects of interferon alpha on B cell differentiation and activation in SLE
A De Groof, J Ducreux, F Aleva, AJ Long, A Ferster, A van der Ven, ...
Rheumatology 59 (3), 668-677, 2020
12020
Overexpression of ubiquitin-specific peptidase 15 in systemic sclerosis fibroblasts increases response to transforming growth factor β
C Galant, J Marchandise, MS Stoenoiu, J Ducreux, A De Groof, S Pirenne, ...
Rheumatology 58 (4), 708-718, 2019
12019
STAT3 phosphorylation mediates the stimulatory effects of interferon alpha on B cell differentiation and activation in SLE
J Ducreux, F Aleva, A Degroof, A Ferster, A van der Ven, ...
Arthritis & rheumatology 68, 2016
12016
Increased CD95 (Fas) Expression on Naive B Cells Is Associated with a Switch to Double Negative and Plasma Cells in the Peripheral Blood, and Correlates with Disease Activity …
J Ducreux, S Nieuwland, F Houssiau, B Lauwerys
Arthritis & Rheumatology 66, 2014
12014
Global Molecular Effects of Tocilizumab Therapy in Synovial Biopsies of Early Rheumatoid Arthritis Patients
J Ducreux, A Nzeusseu Toukap, C Galant, F Houssiau, P Durez, ...
76th Annual American College of Rheumatology meeting, 2012
12012
Toll-like receptor 3 increases antigen-presenting cell responses to a pro-apoptotic stimulus, yet does not contribute to systemic lupus erythematosus genetic susceptibility.
A De Groof, J Ducreux, L Vidal-Bralo, D Tyteca, C Galant, L Marot, ...
Clinical and experimental rheumatology, 2020
2020
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20